MIRA INFORM REPORT

 

 

Report Date :

01.12.2012

 

IDENTIFICATION DETAILS

 

Name :

KERRY (NL) B.V.

 

 

Registered Office :

Veluwezoom 62 1327AH Almere

 

 

Country :

Netherlands

 

 

Financials (as on) :

31.12.2010

 

 

Date of Incorporation :

16.11.1964

 

 

Reg. No.:

33284663

 

 

Legal Form :

Private Company

 

 

Line of Business :

Manufacture of food products and basic pharmaceutical products

 

 

No. of Employees :

21.997

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2011)

Current Rating

(30.06.2012)

Netherlands

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

Netherlands - ECONOMIC OVERVIEW

 

The Dutch economy is the fifth-largest economy in the euro-zone and is noted for its stable industrial relations, moderate unemployment and inflation, a sizable trade surplus, and an important role as a European transportation hub. Industrial activity is predominantly in food processing, chemicals, petroleum refining, and electrical machinery. A highly mechanized agricultural sector employs only 2% of the labor force but provides large surpluses for the food-processing industry and for exports. The Netherlands, along with 11 of its EU partners, began circulating the euro currency on 1 January 2002. After 26 years of uninterrupted economic growth, the Dutch economy - highly dependent on an international financial sector and international trade - contracted by 3.5% in 2009 as a result of the global financial crisis. The Dutch financial sector suffered, due in part to the high exposure of some Dutch banks to U.S. mortgage-backed securities. In 2008, the government nationalized two banks and injected billions of dollars of capital into other financial institutions, to prevent further deterioration of a crucial sector. The government also sought to boost the domestic economy by accelerating infrastructure programs, offering corporate tax breaks for employers to retain workers, and expanding export credit facilities. The stimulus programs and bank bailouts, however, resulted in a government budget deficit of 5.3% of GDP in 2010 that contrasted sharply with a surplus of 0.7% in 2008. The government of Prime Minister Mark RUTTE began implementing fiscal consolidation measures in early 2011, mainly reductions in expenditures, which resulted in an improved budget deficit of 3.8% of GDP.

 

Source : CIA

 


CONTACT INFORMATION   

 

Company name

KERRY (NL) B.V.

Tradename

Kerry (NL) B.V.

 

Kerry Ingredients & Flavours

 

Kerry Bio-Science

Address

Veluwezoom 62

 

1327AH Almere

 

Netherlands

Mail address

Postbus 60037

 

1320AA Almere

 

Netherlands

Telephone number

0365233100

Telefax number

0365233110

Mobile phone

0652346240

E-mail address

reception.almere@kerry.com

Website

www.kerrygroup.com

VAT number / RSIN

001285014

Branch(es)

Kerry NL B.V. (33284663.0001)

 

Maarssenbroeksedijk 2 a

 

3542DN UTRECHT

 

Kerry NL B.V. (33284663.0002)

 

Lindtsedijk 8

 

3336LE ZWIJNDRECHT

 

Kerry NL B.V. (33284663.0003)

 

Swaardvenstraat 41

 

5048AV TILBURG

 

Special remarks

Information about Kerry group(2009):

 

Employees: 21.997

 

Revenue: 4.520.746.000

 

Profit: 251.966.000

 

Equity: 1.284.055.000

 

 

COMPANY INFORMATION  

 

Handelsregisternummer

33284663

Registered in

Chamber of commerce Gooi-, Eem- en Flevoland

First registration

19-11-1964

Act of foundation

16-11-1964

Date of constitution

05-01-1983

Last change in statutes

01-01-2010

Legal form

Private Company

Place of constitution

Almere

Capital

EUR

Issued capital

EUR 22.890

Paid up capital

EUR 22.890

 

NACE-code                                           Manufacture of jam (153301)

Manufacture of other food products n.e.c. (1589)

Manufacture of basic pharmaceutical products (2441)

 

SBI-code Formal objective          Processing of vegetables and fruit (no juice) (1039)

Productie, import en export van voedings- ingredienten, in het bijzonder de productie van grondstoffen (emulgatoren, protel'nen, hydrocolloi'den, gist, enzymen en pharmaceu-tische gefermenteerde ingredienten) voor het gebruik in bakkerijen, manufacture of beer, snoepgoed, zuivelproducten, soepen, sauzen, dressings, snacks en voor de pharmaceutische industrie.

 

Employees

Total: 236

 

 

 

Bookyear

 

2012

2011

2010

Number

 

236

236

236

Change

 

0,00%

0,00%

 

 

 

COMPANY STRUCTURE

 

Shareholder                Kerry Group B.V. Veluwezoom 62

1327AH ALMERE

Netherlands

KvK: 24234571

Active since: 13-11-1992

Percentage: 100.00%

 

Holding company           Kerry Group B.V.

                                       Veluwezoom 62

                                       1327AH ALMERE

                                       KvK: 24234571

 

 

Bank                             ABN Amro Bank NV

                                    Account Number: 50.60.36.251

 

 

 

MANAGEMENT

 

Management                           P.S. Mc Carthy Paul Standish

Authorization: Fully authorized

Position: Manager

Date appointed: 30-06-2008

Date of birth: 24-09-1957

 

 

B.C. Mehigan Brian Cornelius

Authorization: Fully authorized

Position: Manager

Date appointed: 25-02-2002

Date of birth: 01-07-1961

 

W.T. Brouwer Willem Teunis

Authorization: Limited authorization

Position: Proxy

Date appointed: 17-05-2004

Date of birth: 10-03-1963

 

L.H.T. Dederen

Louis Henri Theodore

Authorization: Limited authorization

Position: Proxy

Date appointed: 01-10-2011

Date of birth: 09-02-1956

 

M.I. de Jong Marjolein Ida

Authorization: Limited authorization

Position: Proxy

Date appointed: 17-05-2004

Date of birth: 01-11-1974

 

D. de Muynck Daniel

Authorization: Limited authorization

Position: Proxy

Date appointed: 30-08-2004

Date of birth: 07-08-1974

 

J. Nikerk Johannes

Authorization: Limited authorization

Position: Proxy

Date appointed: 01-06-2010

Date of birth: 24-08-1960

 

J.P. O'Neill James Patrick

Authorization: Limited authorization

Position: Proxy

Date appointed: 01-01-2005

Date of birth: 14-06-1969

 

M.I.M. Tiessen

Menno Ignatius Maria

Authorization: Limited authorization

Position: Proxy

Date appointed: 01-07-2011

Date of birth: 27-07-1958

 

C.J. Visser Cornelia Jantina

Authorization: Limited authorization

Position: Proxy

Date appointed: 17-05-2004

Date of birth: 31-12-1966

PAYMENT INFORMATION

 

Payment experiences     Payments are regular

Payments                     Based on multiple payment experiences up to € 50.000

 

Quarter: 1 2012: 50 Average days

Quarter: 2 2012: 67 Average days

Quarter: 3 2012: 57 Average days

Quarter: 4 2012: 44 Average days

 

 

invoices

current quarter

2012 Q3

2012 Q2

2012 Q1

Total

289

100%

376.424

382.901

366.040

369.101

Within terms

147

64,8%

243.900

131.051

141.972

225.698

Delayed 0 - 30

121

35,2%

132.524

248.984

168.667

120.477

Delayed 31 - 60

20

0,0%

 

2.866

51.582

22.926

Delayed 61 - 90

1

0,0%

 

 

3.819

 

Delayed 91 - 120

 

 

 

 

 

 

Delayed 120+ days

 

 

 

 

 

 

 

 

FINANCIAL INFORMATION

 

Type of publication         Consolidated
Annual accounts van      Kerry Group B.V.

Veluwezoom 62

1327AH ALMERE

KVK: 24234571

Publication                    Publication according to obligations by law

 

CORE FIGURES

 

BOOKYEAR

2010

Quick ratio

0,62

Current ratio

1,04

Nett workingcapital / Balance total

0,01

Capital and reserves / Balance total

0,36

Capital and reserves / Fixed assets

0,51

Solvency

0,60

Nett workingcapital

53.081.000

Capital and reserves

1.626.951.000

Nett Turnover

470.216.000

Operating profit

453.336.000

 

 

Annual accounts

The published financial information is the consolidated group information.

Last annual accounts

2010

Type of publication

Consolidated

Turnover

2010: 470.216.000

Operating profit

2010: 453.336.000

Result after taxes

2010: 324.217.000

Tendency

Not to be judged because of the absence of sufficient financial information

Capital and reserves

2010 1.626.951.000

Total debt

2010 2.692.213.000

Current ratio

2010 1,04

Quick ratio

2010 0,62

Nett workingcapital

2010 53.081.000

Profitability

More than sufficient

Solvency

Positive

Liquidity

Own resources are worn out

Currency

Euro

 

BALANCE

 

 

BOOKYEAR

2010

 

End of bookyear

31-12-2010

 

Intangible assets

1.998.868.000

 

Tangible assets

1.107.164.000

 

Financial assets

59.823.000

 

Fixed assets

3.165.855.000

 

Stocks and work in progress

531.561.000

 

Accounts receivable

628.797.000

 

Liquid assets

159.340.000

 

Current assets

1.319.698.000

 

Total assets

4.485.553.000

 

Capital and reserves

1.626.951.000

Provisions

166.389.000

Long term liabilities

1.425.596.000

Total short term debt

1.266.617.000

Total debt

2.692.213.000

Total Liabilities

4.485.553.000

 

PROFIT & LOSS ACCOUNT

                                                                                

BOOKYEAR

2010

Nett Turnover

470.216.000

Operating charges

16.880.000

Operating profit

453.336.000

Financial income

945.000

Financial charges

61.446.000

Financial result

-60.501.000

Result before taxes

392.835.000

Income taxes

68.618.000

Result after taxes

324.217.000

Nett result

324.217.000

 

 

History

 

Consent statements                   Over bookyear 2011 a consent agreement is filed

Over bookyear 2010 a consent agreement is filed

Over bookyear 2009 a consent agreement is filed

Over bookyear 2008 a consent agreement is filed

 

Merger and demerger                 Op 18-12-2009 merger taken place. New registration: Kerry Bio- Science B.V. (33284663) Ceased registration: Kerry Ingredients B.V. (24283044) ............................................... Op 18-12-2009 merger taken place. New registration: Kerry Bio- Science B.V. (33284663) Ceased registration: Dera Netherlands B.V. (33302380).

Op 13-11-2009 merger proposal filed. New registration: Kerry Bio- Science B.V. (33284663) Ceased registration: Kerry Ingredients B.V. (24283044)

............................................... Op 13-11-2009 merger proposal filed. New registration: Kerry Bio- Science B.V. (33284663) Ceased registration: Dera Netherlands B.V. (33302380).

Op 13-11-2009 merger proposal filed. New registration: Kerry Bio- Science B.V. (33284663) Ceased registration: Kerry Ingredients B.V. (24283044)

............................................... Op 13-11-2009 merger proposal filed. New registration: Kerry Bio- Science B.V. (33284663) Ceased registration: Dera Netherlands

B.V. (33302380).

 

Management                             Per 01-01-2012 is Proxy Cathal Xavier Duffy out of office.

Per 01-10-2011 is Proxy Louis Henri Theodore Dederen appointed.

Per 01-07-2011 is Proxy Menno Ignatius Maria Tiessen appointed.

Per 01-06-2011 is Proxy Merel Jonkman out of office.

Per 01-05-2010 is Proxy Constantinus Maria Broekhuizen out of office.

Per 01-06-2010 is Proxy Johannes Nikerk appointed.

Per 01-01-2010 is Proxy Soetiemin Amatsahlan out of office.

Per 01-01-2010 is Proxy Johannes Groen out of office.

Per 01-01-2010 is Proxy Soetiemin Amatsahlan appointed.

Per 01-01-2010 is Proxy Johannes Groen appointed.

Per 01-01-2010 is Proxy Johannes Nikerk appointed.

Per 01-09-2009 is Proxy Adrianus Cornelis Huigen out of office.

 

Modifications                             Per 01-09-2009 is Proxy Gertjan Feenstra out of office.

Per 18-12-2009 statutes modified. Per 1-1-2010 name changed to: Kerry (NL) B.V..

 

 

Company structure

 

• Kerry Group B.V. (24234571) ALMERE

o Kerry (NL) B.V. (33284663) Almere

Subsidiary (100%)


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.52

UK Pound

1

Rs.87.48

Euro

1

Rs.70.89

 

 

INFORMATION DETAILS

 

Report Prepared by :

SDA

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.